Targeted therapies for autoimmune/idiopathic nonmalignant diseases: risk and management of opportunistic infections
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2020.1767585
Abstract: ABSTRACT Introduction The management of patients affected by autoimmune/idiopathic diseases has been revolutionized by the development of targeted therapies (TT). However, the use of TT is complicated by several adverse events, like opportunistic infections (OIs).… read more here.
Keywords: autoimmune idiopathic; management opportunistic; therapies autoimmune; management ... See more keywords
The role of regulatory T cells, interleukin-10 and in vivo scintigraphy in autoimmune and idiopathic diseases - Therapeutic perspectives and prognosis.
Sign Up to like & getrecommendations! Published in 2017 at "Revista da Associacao Medica Brasileira"
DOI: 10.1590/1806-9282.63.12.1090
Abstract: Previous studies have demonstrated the expression of the CD25 marker on the surface of naturally occurring T cells (Tregs) of mice, which have a self-reactive cellular profile. Recently, expression of other markers that aid in… read more here.
Keywords: idiopathic diseases; autoimmune idiopathic; autoimmune; prognosis ... See more keywords